A detailed history of Sanctuary Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 10,332 shares of CORT stock, worth $780,479. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,332
Previous 9,296 11.14%
Holding current value
$780,479
Previous $682 Million 72.96%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

BUY
$67.17 - $83.9 $69,588 - $86,920
1,036 Added 11.14%
10,332 $1.18 Billion
Q2 2025

Jan 06, 2026

SELL
$62.24 - $91.93 $64,480 - $95,239
-1,036 Reduced 10.03%
9,296 $682 Million
Q1 2025

Jan 06, 2026

SELL
$49.85 - $114.22 $943,461 - $2.16 Million
-18,926 Reduced 64.69%
10,332 $1.18 Billion
Q4 2024

Jan 31, 2025

BUY
$44.66 - $60.85 $40,417 - $55,069
905 Added 3.19%
29,258 $2.05 Billion
Q3 2024

Nov 25, 2024

BUY
$29.51 - $46.26 $836,697 - $1.31 Million
28,353 New
28,353 $1.63 Billion

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.